ritonavir and Sexual-Dysfunction--Physiological

ritonavir has been researched along with Sexual-Dysfunction--Physiological* in 1 studies

Other Studies

1 other study(ies) available for ritonavir and Sexual-Dysfunction--Physiological

Article	Year
Sexual dysfunction secondary to gemfibrozil. Pharmacotherapy, 2002, Volume: 22, Issue:1 Hypertriglyceridemia is a well-recognized complication of protease inhibitor therapy, specifically ritonavir. Fibrate derivatives are recommended as first-line therapy for isolated triglyceride elevations, and gemfibrozil has been successful for managing protease inhibitor-induced lipid changes. A 35-year-old man experienced sexual dysfunction 3 weeks after starting gemfibrozil. The temporal relationship and improvement in sexual function after the drug was discontinued suggest that gemfibrozil may have been responsible for his sexual dysfunction. Topics: Adult; Gemfibrozil; HIV Protease Inhibitors; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Male; Penile Erection; Ritonavir; Sexual Dysfunction, Physiological	2002

Article

Year

Sexual dysfunction secondary to gemfibrozil.

Pharmacotherapy, 2002, Volume: 22, Issue:1

Hypertriglyceridemia is a well-recognized complication of protease inhibitor therapy, specifically ritonavir. Fibrate derivatives are recommended as first-line therapy for isolated triglyceride elevations, and gemfibrozil has been successful for managing protease inhibitor-induced lipid changes. A 35-year-old man experienced sexual dysfunction 3 weeks after starting gemfibrozil. The temporal relationship and improvement in sexual function after the drug was discontinued suggest that gemfibrozil may have been responsible for his sexual dysfunction.

Topics: Adult; Gemfibrozil; HIV Protease Inhibitors; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Male; Penile Erection; Ritonavir; Sexual Dysfunction, Physiological

2002